- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00462969
Cytologic Analysis of Distention Media as a Screening Test for Endometrial Cancer
November 15, 2019 updated by: University of Wisconsin, Madison
The purpose of this study is to learn fluid from sonohysterography can be used to diagnose endometrial cancer.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Participants will have a sonohysterography (SHG) performed.
Fluid will be collected after instillation of 5mls of saline and again after an adequate SHG is performed.
A pathologist will review this fluid to see is cancer cells are present.
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Wisconsin
-
Madison, Wisconsin, United States, 553792
- University of Wisconsin
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Newly diagnosed early-stage endometrial cancer
Exclusion Criteria:
- Recurrent or persistent endometrial cancer
- Evidence of distant metastases
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1
pre-surgical SHG
|
Sonohysterography
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Cytology results
Time Frame: At completion of enrollment
|
At completion of enrollment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2007
Primary Completion (Actual)
September 1, 2010
Study Completion (Actual)
September 1, 2010
Study Registration Dates
First Submitted
April 17, 2007
First Submitted That Met QC Criteria
April 18, 2007
First Posted (Estimate)
April 19, 2007
Study Record Updates
Last Update Posted (Actual)
November 19, 2019
Last Update Submitted That Met QC Criteria
November 15, 2019
Last Verified
January 1, 2015
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CC06701
- P30CA014520 (U.S. NIH Grant/Contract)
- A532820 (Other Identifier: UW Madison)
- H-2006-0333 (Other Identifier: Health Sciences Institutional Review Board)
- NCI-2014-01355 (Registry Identifier: NCI Trial ID)
- SMPH\OBSTET & GYNECOL\ONC (Other Identifier: UW Madison)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Endometrial Cancer
-
Assistance Publique - Hôpitaux de ParisUniversité Montpellier; Ecole d'econmie de Paris (PSE)-Hospinnomics; Université...CompletedEndometrial Cancer Stage I | Endometrial Cancer Stage IIFrance
-
Radboud University Medical CenterMaastricht University Medical Center; Erasmus Medical Center; Catharina Ziekenhuis... and other collaboratorsRecruitingEndometrial Cancer Recurrent | Endometrial Cancer Stage III | Endometrial Cancer Stage IVNetherlands
-
Batman Training and Research HospitalEskisehir Osmangazi UniversityCompletedGynecologic Cancer | Endometrial Cancer Stage
-
Samsung Medical CenterRecruitingEndometrial Cancer Stage IKorea, Republic of
-
Duke UniversityDuke Cancer InstituteCompleted
-
Far Eastern Memorial HospitalCompletedOutcome of Endometrial CancerTaiwan
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingAdvanced Endometrial CancerChina
-
Novartis PharmaceuticalsCompletedAdvanced Endometrial CancerBelgium, France, Italy, Canada, Spain, Australia, Germany, United States, Japan, Brazil, Singapore, Russian Federation, Poland
-
Rambam Health Care CampusCompletedSerous Papillary Endometrial CancerIsrael
-
Masonic Cancer Center, University of MinnesotaCompletedCervical Cancer | Ovarian Cancer | Uterine Endometrial CancerUnited States
Clinical Trials on Sonohysterography
-
Sohag UniversityNot yet recruitingCesarean Section Niche Evaluation
-
Ain Shams UniversityUnknown
-
University of Wisconsin, MadisonCompleted
-
Aljazeera HospitalCompleted
-
Royan InstituteCompleted
-
Woman's Health University Hospital, EgyptUnknownGynecologic DiseaseEgypt
-
Ludwin & Ludwin Gynecology, Private Medical CenterJagiellonian University; University of Sao PauloCompletedInfertility, | Abortions, Spontaneous, HabitualPoland
-
Cook Group IncorporatedTerminatedUterine Neoplasms | Polycystic Ovary Syndrome | Endometrial Neoplasms | MenorrhagiaPanama
-
Cairo UniversityCompleted